Yongwoo David Seo
University of Washington, The University of Texas MD Anderson Cancer Center
Papers
3
Total Citations
127
H-Index
3
About
Dr. Yongwoo David Seo is a leading hepatobiliary and pancreatic surgeon whose research focuses on advancing minimally invasive surgical techniques, particularly robotic hepatectomy and pancreatoduodenectomy. His major contributions center on defining the safety, efficacy, and cost-effectiveness of robotic liver surgery. His landmark 2016 study, cited 90 times, critically examined whether robotic hepatectomy is cost-prohibitive, providing essential data for hospital adoption. Dr. Seo further advanced the field by applying the IWATE difficulty scoring system to robotic liver resections in a 2021 study of 225 cases (34 citations), demonstrating that these criteria effectively predict perioperative outcomes and help guide surgical planning. His work on robotic pancreatoduodenectomy for pancreatic cancer, including a 2022 video manuscript, emphasizes the importance of meticulous vascular dissection quality. Through these contributions, Dr. Seo has helped establish evidence-based benchmarks for robotic hepatobiliary surgery, directly impacting clinical decision-making and patient outcomes. His research continues to shape how surgeons approach complex minimally invasive procedures, balancing technical innovation with practical considerations of cost and oncologic safety.
Research Focus
Key Achievements
Top Papers
- 1Efficacy and cost of robotic hepatectomy: is the robot cost-prohibitive?90 citations · 2016
- 2
- 3